From Wikipedia, the free encyclopedia
(Redirected from CJC-1295)
|This article relies too much on references to primary sources. (September 2008)|
|Public (TSX has Delisted this Stock)|
|Headquarters||Montreal, Quebec, Canada|
|Products||Drug Affinity Construct (DAC) and Preformed Conjugate-Drug Affinity Construct (PC-DAC)|
Number of employees
It employs 45 people, 90% of whom are in research and development.
- "Company Profile for ConjuChem Biotechnologies Inc. (CA;CJB)". Retrieved 2008-10-14.
|This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.|